Cyclophosphamide (UK) — Patient Information

Cyclophosphamide is a powerful chemotherapy medicine used to treat a range of cancers and some severe immune-related conditions. It belongs to a group of medicines called alkylating agents. In the UK, cyclophosphamide is available in different formulations depending on the treatment setting, and it is used by specialist clinicians as part of carefully planned therapy.

This page explains what cyclophosphamide is, how it works, how it behaves in the body, what it’s used for, and what to expect regarding safety, monitoring, interactions, and practical tips. It is written for general understanding and does not replace advice from your clinical team.

1. Basic product information

• Medicine name: Cyclophosphamide
• Class: Alkylating chemotherapy agent (nitrogen mustard derivative)
• Common dosage forms (varies by product): tablets, capsules, and injections
• How it is given: by mouth (oral) and/or by injection/infusion in hospital or clinic
• Typical setting: oncology/haematology units; sometimes specialist immunology/renal services
• ATC code (general): L01AA01 (cyclophosphamide)

Brand names and exact strengths depend on the manufacturer and formulation supplied in the UK. Your treatment centre will provide the specific product details relevant to you.

2. How cyclophosphamide works (mechanism of action)

Cyclophosphamide is a prodrug, meaning it is converted in the body to active forms. After absorption, it is metabolised—mainly in the liver—into compounds that can damage DNA.

The active metabolites form alkyl groups that attach to DNA, interfering with DNA replication and cell division. This is especially harmful to rapidly dividing cells, such as cancer cells and certain overactive immune cells.

• Primary action: DNA cross-linking and DNA damage
• Effect on cells: reduced proliferation and increased cell death
• Clinical outcomes: tumour reduction and/or suppression of harmful immune activity

Because cyclophosphamide also affects healthy rapidly dividing cells (such as bone marrow cells and parts of the immune system), side effects like lowered blood counts can occur and monitoring is essential.

3. Pharmacokinetics (how the body handles the medicine)

“Pharmacokinetics” describes what the body does to the medicine—absorption, distribution, metabolism, and elimination. The exact profile can vary between individuals and with formulation and treatment regimen.

Absorption

For oral formulations, cyclophosphamide is absorbed from the gastrointestinal tract. Food may influence the timing and rate of absorption for some medicines; your clinician/pharmacist will advise on the best way to take your specific product.

Distribution

Once absorbed, cyclophosphamide (and its metabolites) distributes throughout the body, including tissues involved in metabolism and immune activity.

Metabolism

Cyclophosphamide is metabolised mainly in the liver. The active metabolites are formed through enzymatic pathways, and inactive metabolites are also produced. This means liver function can influence how the medicine is processed.

Elimination

Cyclophosphamide and its metabolites are eliminated primarily through the kidneys in urine. This is one reason why careful urinary monitoring may be part of therapy.

Half-life (general concept)

The “half-life” can differ between the parent drug and active metabolites. In practice, timing is managed by clinicians using blood tests and treatment schedules rather than relying on half-life alone.

4. Typical use in the UK

Cyclophosphamide is used in specialist care for certain cancers and, in selected cases, severe immune-mediated diseases. The most appropriate use depends on the diagnosis, disease stage, other treatments, and your overall health.

Common cancer-related indications

• Lymphomas (including some Hodgkin and non-Hodgkin lymphoma regimens)
• Leukaemia in specific combination regimens
• Breast cancer in certain protocols
• Germ cell tumours (where cyclophosphamide may be included)
• Other solid tumours depending on specialist regimen

Immune-related (immunosuppressive) indications

In some severe autoimmune conditions, cyclophosphamide can be used to suppress immune system activity. Examples include certain serious inflammatory disorders, particularly when other treatments are not suitable. Your specialist team will confirm whether cyclophosphamide is appropriate for your diagnosis.

If you are unsure why cyclophosphamide is being used in your case, ask your clinical team to explain the goal of therapy (for example, cure, disease control, remission induction, or maintenance).

5. Indications and treatment goals

“Indication” means the medical reason a medicine is used. Cyclophosphamide may be used with the aim of:

• Remission induction: reducing disease activity quickly
• Remission consolidation: continuing treatment to strengthen response
• Maintenance (in selected regimens): keeping disease under control
• Immune suppression: controlling severe autoimmune inflammation

Because cyclophosphamide can be used in many combination regimens, your exact plan (dose, schedule, supportive medicines) will be tailored by specialists.

6. Dosing and timing

Dosing depends on several factors, including your diagnosis, body surface area or weight, kidney function, liver function, other medications, and whether the regimen is curative or supportive. Therefore, the information below is general guidance. Always follow your clinical team’s schedule for your specific course.

Typical scheduling (concepts)

• Oral regimens: often taken once daily or in cycles with rest periods, depending on the protocol
• IV regimens (injection/infusion): commonly given at defined intervals (e.g., every few weeks) in hospital
• Cycles and rest: many chemotherapy regimens include planned breaks to allow blood counts to recover

When to take it (timing)

• If your medicine is oral, take it at the same time each day as directed.
• You may be advised to take it with food or on an empty stomach depending on the formulation. Follow the instructions provided with your specific product.
• Hydration is often encouraged during treatment to help protect the urinary tract—follow your care team’s advice.

If you miss a dose, do not try to “catch up” without advice. Contact your treatment team or pharmacist for guidance.

7. Food interactions and dietary considerations

Food interactions with cyclophosphamide can depend on the formulation. In general:

• Do not change your diet drastically or start high-dose supplements without checking with your clinician/pharmacist.
• Grapefruit and grapefruit juice: may affect the metabolism of some medicines. Cyclophosphamide can be sensitive to drug metabolism pathways. It’s safest to avoid grapefruit products unless your clinician confirms they are acceptable.
• St John’s wort: can reduce levels of many medicines by affecting liver enzymes and should usually be avoided during chemotherapy.

If you have specific dietary needs (for example, diabetes, allergies, or swallowing difficulties), ask your pharmacist about suitable ways to take your tablets/capsules.

8. Alcohol and medicine interactions

Alcohol

It is generally advisable to limit or avoid alcohol during chemotherapy. Alcohol may:

• worsen fatigue
• increase the risk of nausea or stomach irritation
• affect liver function, which is important because cyclophosphamide is metabolised in the liver

Your clinician can advise what is safe for you based on your liver function tests and overall treatment plan.

Medicine interactions (important)

Cyclophosphamide can interact with other medicines that affect liver enzymes, kidney function, or blood cell counts. Discuss all of the following with your pharmacist or specialist team:

• Other chemotherapy and anti-cancer medicines
• Immunosuppressants (may increase infection risk)
• Warfarin or other anticoagulants (blood counts and nutrition changes may affect clotting and bleeding risk)
• Anti-epileptics (some enzyme-inducing drugs can change cyclophosphamide metabolism)
• Allopurinol or medicines affecting uric acid (tumour lysis risk may be considered in oncology)
• Live vaccines (often avoided during immunosuppression)
• Herbal products such as St John’s wort

Always provide your full medication list (including over-the-counter products and herbal remedies) at each review. If you are starting a new medicine, ask whether it could interact with cyclophosphamide.

9. Safety profile: what to expect and what to monitor

Cyclophosphamide can cause side effects because it affects rapidly dividing cells, including bone marrow cells. Side effects vary widely by dose, schedule, combination therapy, your health status, and your blood test results.

Key safety risks

• Lowered blood counts (myelosuppression): increased risk of infection, anaemia, and bleeding/bruising
• Infection risk: fever can be serious while blood counts are low
• Bladder/urinary tract irritation: cyclophosphamide metabolites can irritate the bladder in some cases
• Nausea and vomiting
• Hair loss (may occur depending on regimen and dose intensity)
• Fatigue
• Sexual and fertility effects: may affect fertility in men and women
• Risk of secondary cancers: a small long-term risk exists with alkylating agents

Common side effects (may include)

• Nausea, vomiting, loss of appetite
• Diarrhoea or constipation
• Sore mouth or mouth ulcers
• Skin rash or dryness
• Reduced blood counts leading to tiredness, infections, or easy bruising
• Hair thinning (depending on regimen)

Less common but urgent symptoms

Seek urgent medical help if you experience:

• Fever (commonly defined by your care team’s instructions—often ≥ 37.5°C or ≥ 38.0°C)
• Signs of severe infection: chills, severe cough, shortness of breath
• Unusual bleeding (nose/gums, blood in urine, black stools, heavy bruising)
• Blood in urine or painful urination
• Severe or persistent vomiting or inability to keep fluids down
• Severe allergic reaction symptoms: swelling of face/lips, wheezing, severe rash

Monitoring during treatment

Your clinician will arrange regular tests. These often include:

• Full blood count (FBC): monitor white cells, haemoglobin, and platelets
• U&Es / kidney function tests: check hydration status and renal clearance
• Liver function tests (LFTs): cyclophosphamide is metabolised in the liver
• Urinalysis: to look for blood/protein or bladder irritation, depending on regimen
• Other tests: depending on your diagnosis (e.g., imaging, infection screening)

10. Practical use tips (how to get through treatment safely)

Handling the medicine

• If you have oral cyclophosphamide at home, handle it carefully and keep it away from children.
• Wash hands after handling the tablets/capsules.
• Do not crush, open, or chew tablets/capsules unless your pharmacist specifically instructs you to.

Hydration and urinary comfort

Because metabolites are excreted in urine, adequate hydration may be advised to reduce bladder irritation risk. Follow your care team’s hydration recommendations. Report urinary symptoms promptly.

Managing nausea and appetite changes

• Your clinician may prescribe anti-sickness medicines; use them as directed.
• Eat small, frequent meals if large meals worsen nausea.
• Stay hydrated with water or oral rehydration fluids if recommended.

Blood count safety at home

• Understand your unit’s instructions for temperature monitoring.
• Avoid close contact with people who have active infections where possible.
• Ask whether you should avoid crowds or wear a mask in higher-risk situations.

Fertility and contraception

Cyclophosphamide can affect fertility. If this is relevant to you, discuss fertility preservation options before treatment begins.

• Pregnancy prevention: pregnancy should be avoided during cyclophosphamide treatment.
• Contraception: your specialist team will advise the appropriate contraception method for your situation and duration.
• Breastfeeding: ask your clinician/pharmacist for specific guidance.

11. Alternative options

“Alternative options” depend entirely on what cyclophosphamide is treating, the stage/severity, and your prior treatments. In many cancer regimens, there may be other chemotherapy agents with different side-effect profiles. In immune-mediated disease, other immunosuppressants may be considered depending on diagnosis and severity.

Examples of alternatives (not a complete list) may include:

• Other chemotherapy agents used in combination regimens (selected by tumour type)
• Immunosuppressive medicines such as mycophenolate mofetil, azathioprine, methotrexate, or biologic therapies (depending on the condition)
• Supportive care adjustments such as antiemetics, growth factors, or tailored dosing schedules

Your oncology or specialist immunology team can explain why cyclophosphamide is selected and what other approaches may be available. Do not stop or switch treatment without medical advice.

12. Market and legal context in the United Kingdom (UK)

In the UK, cyclophosphamide is a high-risk cytotoxic medicine used under specialist supervision. Medicines of this type are typically supplied through approved routes and used in licensed treatment settings. Regulatory and prescribing arrangements are designed to ensure safe handling, appropriate monitoring, and correct patient identification.

Access to chemotherapy medicines is governed by UK healthcare pathways, including hospital pharmacy services and NHS (or private) specialist providers. Treatment decisions must follow relevant clinical guidance and safety requirements.

Recent guidance (general)

UK clinical practice is guided by evidence-based oncology and immunology standards, including:

• protocols for dosing adjustments based on blood counts and organ function
• infection risk management and prompt fever evaluation during treatment
• urinary tract protection strategies when appropriate
• fertility and safeguarding considerations for patients of childbearing potential

Because “recent guidance” can vary by cancer type and by the condition being treated, your care team will follow the most current protocol for your specific diagnosis and regimen.

13. Delivery, availability, and what to expect

Availability can depend on the exact formulation and strength. In the UK, cyclophosphamide medicines are typically supplied through specialist channels because they require safe handling and careful monitoring.

If you are receiving cyclophosphamide via oral tablets/capsules, a UK online pharmacy may deliver medicines to your home where legally permitted and clinically appropriate. Delivery options, storage instructions, and lead times vary by supplier and product.

Storage

• Store in a safe place, away from children.
• Keep at the temperature and conditions stated on the packaging.
• Do not use after the expiry date shown on the carton/blister.

Packaging and safety on arrival

• Check the medicine name and strength match what you were expecting.
• Ensure the product is intact (no damage to the blister or bottle seal).
• If anything looks unusual, contact the pharmacy promptly.

For hospital-administered cyclophosphamide (injection/infusion), the medicine is supplied and administered by clinical teams.

14. Cyclophosphamide FAQ

What is cyclophosphamide used for?

Cyclophosphamide is used as chemotherapy for certain cancers and, in some situations, to suppress severe immune activity in specific immune-mediated conditions. Your specialist team can explain the goal in your case.

How long does treatment take?

Treatment length varies widely depending on diagnosis and regimen. Many chemotherapy schedules are delivered in cycles with planned rest periods to allow recovery of blood counts. Your care plan will specify the number and timing of cycles.

When should I call my doctor or treatment team urgently?

Contact urgent care immediately if you develop fever or signs of infection, unusual bleeding, blood in urine, severe persistent vomiting, severe pain, or symptoms of a serious allergic reaction. Follow your team’s “fever” threshold and contact pathway instructions.

Can I drink alcohol while taking cyclophosphamide?

It’s usually best to limit or avoid alcohol during treatment. Alcohol can worsen side effects and may affect liver function. Ask your clinician for personalised advice.

Are there foods I should avoid?

Avoid or limit items that can interfere with medicine metabolism (for example, grapefruit products). Also avoid herbal supplements such as St John’s wort unless your clinician confirms they’re safe. Follow the specific instructions provided with your cyclophosphamide formulation.

Do I need any special blood tests?

Yes. Regular blood tests are standard to monitor blood counts and organ function. This helps reduce the risk of complications and informs dose adjustments.

Will cyclophosphamide affect my fertility?

It can. If you may want children in the future, discuss fertility preservation options before starting treatment. Your clinical team can guide you on contraception and long-term considerations.

What should I do if I miss a dose?

Do not take extra doses without advice. Contact your pharmacy or treatment team for guidance.

What are the most common side effects?

Common side effects include nausea, tiredness, lowered blood counts, and mouth changes. The exact pattern depends on the dose and regimen. Your care team can provide a tailored list of expected effects.

Are vaccines safe during treatment?

Vaccine guidance during chemotherapy often differs by vaccine type. Live vaccines are commonly avoided during immunosuppression. Ask your care team or pharmacist for advice before receiving any vaccine.

15. Summary

Cyclophosphamide is a high-impact chemotherapy and immunosuppressive medicine used in specialist care for certain cancers and severe immune-mediated diseases. It works by damaging DNA after activation in the body. Because it can lower blood counts and irritate the bladder, careful monitoring and prompt reporting of symptoms are essential. With appropriate supportive medicines, hydration, and blood test schedules, many people can receive treatment safely under specialist supervision.

If you have questions about your specific regimen—dose schedule, side-effect expectations, or interactions—speak to your pharmacist or clinical team.